| 103948-6 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.1 during assessment period | PANEL.SURVEY.CMS |
| 103949-4 | Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.1 during assessment period | PANEL.SURVEY.CMS |
| 10395-2 | Factor VIII given | BLDBK |
| 103950-2 | NOTCH3 gene full mutation analysis in Specimen (molecular genetics method) | MOLPATH.MUT |
| 103951-0 | Motor neuron disease multigene analysis in Specimen (molecular genetics method) | MOLPATH.MUT |
| 103952-8 | Muscular dystrophy multigene analysis in Specimen (molecular genetics method) | MOLPATH.MUT |
| 103953-6 | HIF2A gene targeted mutation analysis (Blood, molecular genetics method) | MOLPATH.MUT |
| 103954-4 | Peripheral neuropathy multigene analysis in Specimen (molecular genetics method) | MOLPATH.MUT |
| 103955-1 | KRAS Somatic mutation analysis in Tumor (molecular genetics method) | MOLPATH.MUT |
| 103956-9 | Parkinson Disease multigene analysis in Specimen (molecular genetics method) | MOLPATH.MUT |
| 103957-7 | Neuromuscular multigene analysis in Specimen (molecular genetics method) | MOLPATH.MUT |
| 103958-5 | Ofloxacin (qualitative, genotype method) | ABXBACT |
| 103959-3 | cycloSERINE (qualitative, genotype method) | ABXBACT |
| 10396-0 | Factor VIII given | BLDBK |
| 103960-1 | Prothionamide (qualitative, genotype method) | ABXBACT |
| 103961-9 | Borrelia burgdorferi.VlsE1+pepC10 Ab (CSF, immunoassay) | MICRO |
| 103962-7 | 11-Ketotestosterone (lc/ms/ms) | CHEM |
| 103963-5 | Zika virus lineage in Specimen (molecular genetics method) | MICRO |
| 103964-3 | Hospice care social worker Note | DOC.ONTOLOGY |
| 103965-0 | Hospice care Interdisciplinary Note | DOC.ONTOLOGY |
| 103966-8 | Hospice care case manager Note | DOC.ONTOLOGY |
| 103967-6 | Hospice care nurse Note | DOC.ONTOLOGY |
| 103968-4 | Hospice care Consult note | DOC.ONTOLOGY |
| 103969-2 | Hospice care Progress note | DOC.ONTOLOGY |
| 10397-8 | Hepatitis B immune globulin given | BLDBK |
| 103970-0 | Cardiology Rehabilitation Note | DOC.ONTOLOGY |
| 103971-8 | Cardiology Rehabilitation progress note | DOC.ONTOLOGY |
| 103972-6 | Cardiology Outpatient Rehabilitation Note | DOC.ONTOLOGY |
| 103973-4 | Paternal age at fetal death | OBGYN |
| 103974-2 | Ectopic pregnancy AndOr abortion | OBGYN |
| 103975-9 | Previous delivery date | OBGYN |
| 103976-7 | Mobility Episode (qualitative) | CLIN |
| 103977-5 | State of commission Notary - Reported | CLIN |
| 103978-3 | Information to tell doctors if you have a sudden injury or illness with a good chance of recovery | SURVEY.ADVAULT |
| 103979-1 | Information to tell the medical team if you stop breathing or your heart stops beating | SURVEY.ADVAULT |
| 10398-6 | I Ag on Red Blood Cells from Blood product unit (qualitative) | BLDBK |
| 103980-9 | Pharmacy preference Narrative - Reported | CLIN |
| 103981-7 | Do you feel physically or emotionally unsafe where you currently live | SURVEY.SDOH |
| 103982-5 | Do you have a food insecurity | SURVEY.SDOH |
| 103983-3 | Do you have a housing insecurity | SURVEY.SDOH |
| 103984-1 | Do you have a travel insecurity | SURVEY.SDOH |
| 103985-8 | Do you have utilities insecurity | SURVEY.SDOH |
| 103986-6 | Do you have a personal safety insecurity | SURVEY.SDOH |
| 10399-4 | I Ag on Red Blood Cells from Donor (qualitative) | BLDBK |
| 103991-6 | CMS - Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 4.2 during assessment period | PANEL.SURVEY.CMS |
| 103996-5 | In 2020 was it you or who was in charge of taking care of these underage persons (qualitative) | SURVEY.COVID |
| 103997-3 | Type of mechanical circulatory support | ADMIN.PATIENT |
| 103998-1 | IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - admission during assessment period | PANEL.SURVEY.CMS |
| 103999-9 | IRF-PAI v4.2, LCDS v5.1, MDS v1.19.1 - Functional abilities - discharge during assessment period | PANEL.SURVEY.CMS |
| 104-0 | Ceforanide (minimum inhibitory concentration (mic)) | ABXBACT |